Wearable Electronic Breath Sound Sensing Device

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age6-17
SponsorEmory University

About this trial

This study will assess the ability of a wearable stethoscope to monitor wheezing in high-risk asthma patients admitted at Children's Healthcare of Atlanta.

This study is important to assist in the health management of patients with chronic lung diseases that can experience exacerbations leading to their health worsening and requiring hospitalization. The population that will be approached for this study will include 10 pediatric subjects hospitalized at Children's Healthcare of Atlanta for an asthma-related exacerbation. Participants will wear the patches for up to 8 hours on their chest and back wall from their date of consent until their hospital discharge. This may range from the participant taking part in 1 to 14 visits that could last up to 8 hours.

Eligibility criteria

Qualifiers

Age 6-17 years

Diagnosis of persistent asthma

Being treated for an acute asthma exacerbation

Parent can speak and understand English

Disqualifiers

Unable to provide consent for the study

History of prematurity

History of other chronic lung conditions - cystic fibrosis, bronchiectasis, or primary ciliary dyskinesia

History of latex allergy or allergy to medical tape adhesive

Trial design

Treatments tested in this trial

  • Wearable stethoscope
  • Routine Clinical lung Auscultation

Treatment groups

25 Participants
are divided into 1 treatment group

Sponsors and collaborators

Emory University

Lead sponsor

Georgia Institute of Technology

Collaborator

Imlay Foundation

Collaborator